AR036055A1 - Derivados aromaticos de acidos dicarboxilicos, procedimiento para su preparacion, medicamentos que contienen dichos compuestos, y uso de dichos compuestos en la preparacion de medicamentos - Google Patents
Derivados aromaticos de acidos dicarboxilicos, procedimiento para su preparacion, medicamentos que contienen dichos compuestos, y uso de dichos compuestos en la preparacion de medicamentosInfo
- Publication number
- AR036055A1 AR036055A1 ARP020102231A ARP020102231A AR036055A1 AR 036055 A1 AR036055 A1 AR 036055A1 AR P020102231 A ARP020102231 A AR P020102231A AR P020102231 A ARP020102231 A AR P020102231A AR 036055 A1 AR036055 A1 AR 036055A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- amino
- compounds
- independently selected
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 239000003814 drug Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 6
- -1 nitro, amino Chemical group 0.000 abstract 5
- 206010028980 Neoplasm Diseases 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 3
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 3
- 125000003282 alkyl amino group Chemical group 0.000 abstract 3
- 125000004429 atom Chemical group 0.000 abstract 3
- 125000002837 carbocyclic group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 210000000496 pancreas Anatomy 0.000 abstract 2
- 210000002307 prostate Anatomy 0.000 abstract 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 102000003964 Histone deacetylase Human genes 0.000 abstract 1
- 108090000353 Histone deacetylase Proteins 0.000 abstract 1
- 206010039491 Sarcoma Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 150000001991 dicarboxylic acids Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 210000001672 ovary Anatomy 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 210000000664 rectum Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 210000003932 urinary bladder Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Abstract
Derivados aromáticos de ácidos dicarboxílicos de fórmula (1), en donde: A representa un anillo fenilo que puede estar sin substituir o substituido con 1, 2 ó 3 substituyentes independientemente seleccionados entre un átomo de halógeno, un grupo alquilo C1-4, trifluormetilo, hidroxi, alcoxi C1-4, nitro, amino, alquilamino C1-4, di[alquil C1-4]-amino, alcanoilamino C1-4, alquilendioxilo C1-3 ó un grupo acilo; ó A representa un anillo tiofeno que puede estar sin substituir o substituido por 1 ó 2 substituyentes independientemente seleccionados entre un átomo de halógeno, un grupo alquilo C1-4, trifluormetilo, hidroxi, alcoxi C1-4, nitro, amino, alquilamino C1-4, di[alquil C1-4]-amino, o un alcanoilamino C1-4, alquilendioxilo C1-3 ó un grupo acilo; y R1 y R2 son los mismos o diferentes entre sí, y son, un átomo de hidrógeno; un grupo alquilo C1-12, ramificado o sin ramificar, el cual puede estar sin substituir o substituido con 1 ó varios substituyentes independientemente seleccionados de un átomo de halógeno, un grupo hidroxi, nitro, amino o por un grupo carbocíclico o por un grupo heterocíclico, y en donde, en una cadena de más de 2 átomos de longitud, uno o varios átomos no adyacentes pueden ser reemplazados por átomos de oxígeno, nitrógeno o azufre, y en donde 2 átomos pueden estar unidos entre sí mediante un doble o triple enlace; un grupo carbocíclico; o un grupo heterocíclico; ó R1 y R2 juntamente con el átomo de nitrógeno forman un anillo de 3-6 miembros el cual puede contener adicionalmente heteroátomos independientemente seleccionados de nitrógeno, oxígeno y azufre, y el cual puede ser anillado por un grupo carbocíclico o por un grupo heterocíclico y el cual puede estar sin substituir o substituido con 1, 2 ó 3 substituyentes independientemente seleccionados entre un átomo de halógeno, un grupo alquilo C1-4, trifluormetilo, hidroxi, alcoxi C1-4, arilo, hetarilo, arilalquilo, arilalquiloxi, ariloxi, alquilendioxi C1-3, nitro, amino, alquilamino C1-4, di[alquil C1-4]-amino, alcanoilamino C1-4, ó acilo; sus enantiómeros, diastereoisómeros, racematos y sales fisiológicamente aceptables de los mismos. Dichos compuestos poseen propiedades contra la proliferación celular y tienen actividad inhibidora de la HDAC. Por lo tanto, estos compuestos son útiles en el tratamiento del cáncer, particularmente en el tratamiento de cánceres de mama, pulmón, colon, recto, estómago, próstata, vejiga, páncreas y ovario. También poseen actividad contra una variedad de leucemias, malignidades linfoideas y tumores sólidos tales como carcinomas y sarcomas en tejidos tales como el hígado, rinón, próstata y páncreas. También se dan a conocer: un procedimiento para su preparación, medicamentos que contienen dichos compuestos, y el uso de dichos compuestos en la preparación de medicamentos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01114496 | 2001-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036055A1 true AR036055A1 (es) | 2004-08-04 |
Family
ID=8177731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020102231A AR036055A1 (es) | 2001-06-15 | 2002-06-13 | Derivados aromaticos de acidos dicarboxilicos, procedimiento para su preparacion, medicamentos que contienen dichos compuestos, y uso de dichos compuestos en la preparacion de medicamentos |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6784173B2 (es) |
| EP (1) | EP1401824B1 (es) |
| JP (1) | JP4195377B2 (es) |
| KR (2) | KR20090059172A (es) |
| CN (1) | CN1271066C (es) |
| AR (1) | AR036055A1 (es) |
| AT (1) | ATE343569T1 (es) |
| AU (1) | AU2002355626B2 (es) |
| BG (1) | BG108450A (es) |
| BR (1) | BR0210424A (es) |
| CA (1) | CA2449804A1 (es) |
| CO (1) | CO5540280A2 (es) |
| CZ (1) | CZ200425A3 (es) |
| DE (1) | DE60215652T2 (es) |
| EC (1) | ECSP034896A (es) |
| ES (1) | ES2272800T3 (es) |
| GT (1) | GT200200121A (es) |
| HR (1) | HRP20031019A2 (es) |
| HU (1) | HUP0401233A3 (es) |
| IL (1) | IL159097A0 (es) |
| MA (1) | MA27041A1 (es) |
| MX (1) | MXPA03011501A (es) |
| NO (1) | NO20035555D0 (es) |
| NZ (1) | NZ529874A (es) |
| PA (1) | PA8548001A1 (es) |
| PE (1) | PE20030086A1 (es) |
| PL (1) | PL366729A1 (es) |
| RS (1) | RS98203A (es) |
| RU (1) | RU2289580C2 (es) |
| SK (1) | SK172004A3 (es) |
| WO (1) | WO2003011851A2 (es) |
| ZA (1) | ZA200309260B (es) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6822267B1 (en) * | 1997-08-20 | 2004-11-23 | Advantest Corporation | Signal transmission circuit, CMOS semiconductor device, and circuit board |
| WO2003076400A1 (en) | 2002-03-13 | 2003-09-18 | Janssen Pharmaceutica N.V. | New inhibitors of histone deacetylase |
| CN100503599C (zh) | 2002-03-13 | 2009-06-24 | 詹森药业有限公司 | 作为组蛋白脱乙酰酶的新颖抑制剂的羰基氨基衍生物 |
| EP1492534B1 (en) * | 2002-04-03 | 2008-06-25 | TopoTarget UK Limited | Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US7098241B2 (en) * | 2002-12-16 | 2006-08-29 | Hoffmann-La Roche Inc. | Thiophene hydroxamic acid derivatives |
| TW200424174A (en) * | 2003-02-06 | 2004-11-16 | Hoffmann La Roche | New TP diamide |
| US7208491B2 (en) * | 2003-02-07 | 2007-04-24 | Hoffmann-La Roche Inc. | N-monoacylated o-phenylenediamines |
| US7375228B2 (en) | 2003-03-17 | 2008-05-20 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| TW200424187A (en) * | 2003-04-04 | 2004-11-16 | Hoffmann La Roche | New oxime derivatives and their use as pharmaceutically active agents |
| US7935724B2 (en) * | 2003-10-09 | 2011-05-03 | Merck Hdac Research, Llc | Thiophene and benzothiophene hydroxamic acid derivatives |
| WO2005065681A1 (en) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer |
| US20050137234A1 (en) * | 2003-12-19 | 2005-06-23 | Syrrx, Inc. | Histone deacetylase inhibitors |
| US7217723B2 (en) | 2004-02-02 | 2007-05-15 | Eisai Co., Ltd. | Heterocyclic compound having oxime group |
| US7521473B2 (en) * | 2004-02-25 | 2009-04-21 | Wyeth | Inhibitors of protein tyrosine phosphatase 1B |
| US20050203081A1 (en) * | 2004-02-25 | 2005-09-15 | Jinbo Lee | Inhibitors of protein tyrosine phosphatase 1B |
| CN1964962A (zh) * | 2004-06-14 | 2007-05-16 | 霍夫曼-拉罗奇有限公司 | 噻吩异羟肟酸衍生物以及它们作为hdac抑制剂的应用 |
| EP1758880A1 (en) | 2004-06-14 | 2007-03-07 | F.Hoffmann-La Roche Ag | Hydroxamates, their manufacture and use as pharmaceutical agents |
| JP2008502626A (ja) * | 2004-06-14 | 2008-01-31 | エフ．ホフマン−ラ ロシュ アーゲー | チオフェン誘導体、それらの製造及び医薬物質としての使用 |
| US8193205B2 (en) | 2004-07-28 | 2012-06-05 | Janssen Pharmaceutica N.V. | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| KR100620488B1 (ko) | 2004-08-13 | 2006-09-08 | 연세대학교 산학협력단 | 신규한 히스톤 디아세틸라아제 억제제 및 이의 제조방법 |
| WO2006066133A2 (en) | 2004-12-16 | 2006-06-22 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US20100087328A1 (en) * | 2005-03-01 | 2010-04-08 | The Regents Of The University Of Michigan | Brm expression and related diagnostics |
| US7604939B2 (en) * | 2005-03-01 | 2009-10-20 | The Regents Of The University Of Michigan | Methods of identifying active BRM expression-promoting HDAC inhibitors |
| JP2008536925A (ja) | 2005-04-20 | 2008-09-11 | メルク エンド カムパニー インコーポレーテッド | ベンゾチオフェンヒドロキサム酸誘導体 |
| GB0509225D0 (en) | 2005-05-05 | 2005-06-15 | Chroma Therapeutics Ltd | Inhibitors of enzymatic activity |
| GB0509223D0 (en) | 2005-05-05 | 2005-06-15 | Chroma Therapeutics Ltd | Enzyme inhibitors |
| JP2008540574A (ja) | 2005-05-11 | 2008-11-20 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
| US7732475B2 (en) * | 2005-07-14 | 2010-06-08 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| GB0518237D0 (en) * | 2005-09-07 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| AR057579A1 (es) * | 2005-11-23 | 2007-12-05 | Merck & Co Inc | Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac) |
| US8088804B2 (en) * | 2005-12-15 | 2012-01-03 | Pfizer Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
| WO2007084390A2 (en) * | 2006-01-13 | 2007-07-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| ES2396986T3 (es) | 2006-01-19 | 2013-03-01 | Janssen Pharmaceutica N.V. | Derivados de piridina y pirimidina como inhibidores de histona desacetilasa |
| GB0603041D0 (en) * | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| GB0619753D0 (en) | 2006-10-06 | 2006-11-15 | Chroma Therapeutics Ltd | Enzyme inhibitors |
| MX2009004279A (es) | 2006-10-30 | 2009-05-22 | Chroma Therapeutics Ltd | Hidroxamatos como inhibidores de histona desacetilasa. |
| GB0713686D0 (en) * | 2007-07-13 | 2007-08-22 | Addex Pharmaceuticals Sa | New compounds 2 |
| EP2205070A4 (en) * | 2007-10-04 | 2011-01-12 | Merck Sharp & Dohme | N-HYDROXY-NAPHTHALINE-DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONDEACETYLASE INHIBITORS |
| AU2009289649B2 (en) | 2008-09-03 | 2016-05-05 | Biomarin Pharmaceutical Inc. | Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors |
| GB0903480D0 (en) | 2009-02-27 | 2009-04-08 | Chroma Therapeutics Ltd | Enzyme Inhibitors |
| JP6250403B2 (ja) | 2011-02-28 | 2017-12-20 | バイオマリン ファーマシューティカル インク | ヒストン脱アセチル化酵素阻害剤 |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| JP6503338B2 (ja) | 2013-03-15 | 2019-04-17 | バイオマリン ファーマシューティカル インコーポレイテッド | Ｈｄａｃ阻害剤 |
| EP2826769A1 (en) | 2013-07-18 | 2015-01-21 | Institut de Recherche pour le Développement ( IRD) | Compounds for the treatment and/or prevention of parasitic diseases and method of production thereof |
| KR101536050B1 (ko) * | 2013-07-30 | 2015-07-13 | 충북대학교 산학협력단 | 신규 이사틴 기반 히드록삼산 및 이를 유효성분으로 포함하는 항암용 조성물 |
| EP3769757A3 (en) * | 2013-10-18 | 2021-10-06 | The General Hospital Corporation | Imaging histone deacetylases with a radiotracer using positron emission tomography |
| ES2694053T3 (es) * | 2014-03-12 | 2018-12-17 | Chong Kun Dang Pharmaceutical Corp. | Compuestos novedosos como inhibidores de histona desacetilasa 6 y composiciones farmacéuticas que comprenden los mismos |
| WO2019185413A1 (en) | 2018-03-27 | 2019-10-03 | Basf Se | Pesticidal substituted cyclopropyl derivatives |
| WO2024123700A1 (en) * | 2022-12-05 | 2024-06-13 | The General Hospital Corporation | Histone deacetylase inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3825554A (en) * | 1969-06-13 | 1974-07-23 | Atlantic Richfield Co | Method for preparing cyclic nitrile carbonates |
| JPS54148743A (en) | 1978-05-12 | 1979-11-21 | Asahi Chem Ind Co Ltd | Production of methoclopramide |
| US5700811A (en) * | 1991-10-04 | 1997-12-23 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and method of use thereof |
| US5369108A (en) * | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
| US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| AUPO721997A0 (en) | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
| KR101026205B1 (ko) | 1999-11-23 | 2011-03-31 | 메틸진 인코포레이티드 | 히스톤 디아세틸라제의 억제제 |
-
2002
- 2002-06-11 US US10/167,677 patent/US6784173B2/en not_active Expired - Fee Related
- 2002-06-12 PA PA20028548001A patent/PA8548001A1/es unknown
- 2002-06-13 SK SK17-2004A patent/SK172004A3/sk unknown
- 2002-06-13 DE DE60215652T patent/DE60215652T2/de not_active Expired - Fee Related
- 2002-06-13 AR ARP020102231A patent/AR036055A1/es unknown
- 2002-06-13 ES ES02791436T patent/ES2272800T3/es not_active Expired - Lifetime
- 2002-06-13 PE PE2002000510A patent/PE20030086A1/es not_active Application Discontinuation
- 2002-06-13 RU RU2003137578/04A patent/RU2289580C2/ru not_active IP Right Cessation
- 2002-06-13 MX MXPA03011501A patent/MXPA03011501A/es active IP Right Grant
- 2002-06-13 AT AT02791436T patent/ATE343569T1/de not_active IP Right Cessation
- 2002-06-13 WO PCT/EP2002/006488 patent/WO2003011851A2/en not_active Ceased
- 2002-06-13 PL PL02366729A patent/PL366729A1/xx not_active Application Discontinuation
- 2002-06-13 BR BR0210424-5A patent/BR0210424A/pt not_active IP Right Cessation
- 2002-06-13 JP JP2003517043A patent/JP4195377B2/ja not_active Expired - Fee Related
- 2002-06-13 IL IL15909702A patent/IL159097A0/xx unknown
- 2002-06-13 AU AU2002355626A patent/AU2002355626B2/en not_active Ceased
- 2002-06-13 CN CNB028120108A patent/CN1271066C/zh not_active Expired - Fee Related
- 2002-06-13 EP EP02791436A patent/EP1401824B1/en not_active Expired - Lifetime
- 2002-06-13 CZ CZ200425A patent/CZ200425A3/cs unknown
- 2002-06-13 HU HU0401233A patent/HUP0401233A3/hu unknown
- 2002-06-13 CA CA002449804A patent/CA2449804A1/en not_active Abandoned
- 2002-06-13 RS YUP-982/03A patent/RS98203A/sr unknown
- 2002-06-13 KR KR1020097010546A patent/KR20090059172A/ko not_active Withdrawn
- 2002-06-13 KR KR1020037016358A patent/KR100910958B1/ko not_active Expired - Fee Related
- 2002-06-13 NZ NZ529874A patent/NZ529874A/xx unknown
- 2002-06-13 HR HR20031019A patent/HRP20031019A2/xx not_active Application Discontinuation
- 2002-06-14 GT GT200200121A patent/GT200200121A/es unknown
-
2003
- 2003-11-27 ZA ZA200309260A patent/ZA200309260B/en unknown
- 2003-12-10 CO CO03108279A patent/CO5540280A2/es not_active Application Discontinuation
- 2003-12-11 EC EC2003004896A patent/ECSP034896A/es unknown
- 2003-12-12 NO NO20035555A patent/NO20035555D0/no not_active Application Discontinuation
- 2003-12-12 MA MA27440A patent/MA27041A1/fr unknown
- 2003-12-15 BG BG108450A patent/BG108450A/xx unknown
-
2004
- 2004-05-17 US US10/847,166 patent/US20040214862A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR036055A1 (es) | Derivados aromaticos de acidos dicarboxilicos, procedimiento para su preparacion, medicamentos que contienen dichos compuestos, y uso de dichos compuestos en la preparacion de medicamentos | |
| AR035513A1 (es) | Derivados de tetrahidropiridina, proceso para prepararlos, composiciones farmaceuticas que los contienen, y uso de dichos compuestos en la preparacion de medicamentos | |
| PE20060504A1 (es) | Derivados de pirimidina en el tratamiento de cancer | |
| FI952920A0 (fi) | 7-halogeeni- ja 7beta,8beta-metano-taksolit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset | |
| HUP0400114A2 (hu) | Daganatellenes N-benzoil-benzolszulfonamid-származékok és az ezeket tartalmazó gyógyászati készítmények | |
| AR029815A1 (es) | Derivados aza-indolicos, un proceso para su preparacion, composicion farmaceutica, un metodo para su elaboracion y el uso de dichos derivados para la manufactura de un medicamento | |
| ATE293102T1 (de) | Naphthalene derivate ,ihre herstellung und verwendung | |
| AR040971A1 (es) | Compuestos pirimido que tienen actividad antiproliferativa | |
| AR052903A1 (es) | Compuestos de bis arilo y heteroarilo sustituidos como antagonistas selectivos de 5ht2a, composiciones farmaceuticas que los contienen y su empleo en el tratamiento de trastornos del sueno. | |
| ES2308299T3 (es) | Tiadiazoles como ligandos de receptores de cxc-y cc-quimioquinas. | |
| DK1109813T3 (da) | Pyrroloindoler, pyridoindoler og azepinoindoler som 5-HT2C-agonister | |
| BR0013952A (pt) | Pteridinonas como inibidores de cinase | |
| AR035532A1 (es) | Diaminotiazoles, composiciones farmaceuticas que los comprenden, intermediarios para la preparacion de dichos compuestos, uso de dichos compuestos en la preparacion de medicamentos, y procesos para la preparacion de dichos compuestos | |
| NO20071794L (no) | Disubstituerte pyrazolobenzodiazepiner nyttige som inhibitorer for CDK2 og angiogenese, og for behandling av bryst, tarm, lunge og prostata cancer | |
| RU2010116253A (ru) | Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила | |
| PE20030703A1 (es) | Inhibidores de la 17b-hidroxiesteroide deshidrogenasa tipo 3 | |
| ECSP034642A (es) | Derivados de tetralona como agentes antitumorales | |
| AR034204A1 (es) | Composiciones y combinaciones de acido nicotinico y derivados del mismo con inhibidor(es) de la absorcion de los esteroles, y el uso de los mismos para preparar medicamentos para el tratamiento para indicaciones vasculares | |
| AR012272A1 (es) | Uso de derivados de 1,2-difenilpirrol para la fabricacion de un medicamento destinado para el tratamiento y prevencion de tumores y caquexia, e inhibir elcrecimiento tumoral y metastasis en un mamifero. | |
| AR043823A1 (es) | Compuestos derivados de oxima, su preparacion y elaboracion de medicamentos que los contienen | |
| DE69504843D1 (de) | 7-äther-taxol ähnliche verbindungen antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen | |
| ES2825348T3 (es) | Compuestos y composición farmacéutica asociados al sistema ubiquitinación-proteasoma | |
| IL159554A0 (en) | Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| AR016198A1 (es) | Un compuesto que es un derivado de distamicina sustituido con acriloilo, su uso, un procedimiento para prepararlo y una composicion farmaceutica que locomprende | |
| AR041481A1 (es) | Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |